Published January 2014, a new report from Amadee+Company analyses and forecasts the tea industry for years 2013-2018. The report is titled,
Tea: the Future Is Green And Herbal-Global Markets, Competitors And Opportunities: 2013-2018 Analysis And Forecasts.
According to Amadee+Company, the global market for tea is very large and estimated at USD15.4 billion in 2013, in terms of production value. While the Black/Other Teas segment is growing modestly (3.9% annually), production of Green Tea is growing rapidly (11% CAGR) and Herbal Teas are growing exponentially (>15% CAGR).
Further, Amadee+Company states that besides being a popular beverage, teas of various kinds can both prevent and cure diseases. This includes heart disease, cancer, diabetes, dementia, oral disease and ageing, among others. The company states that one reason is that tea is very rich in polyphenolic constituents, which have high anti-inflammatory, antioxidant, and antimutagenic properties. They use the example: a typical cup of brewed Green tea contains between 80 and 100 milligrams of polyphenols, with the catechin EGCG (a type of natural phenol) accounting for about 25 to 30 milligrams. Various studies have demonstrated that EGCG can inhibit carcinogenesis and prevent metastasis in established tumors.
Despite the exploding demand for tea, they state, little has been published on this market, especially the Green and Herbal segments. The Amadee+Company report looks in detail at the Tea market. Specifically, it provides:
- A comprehensive overview on the market for Tea products by type, including Black and Other teas (Oolong, White, Yellow, etc.) Green tea, and Herbal teas, e.g. Yerba Mate, Chamomile, Echinacea, Ginseng, etc.
- A thorough review of Tea’s health effects-especially on heart disease, cancer, diabetes, neurological diseases, renal disease, dementia, oral health, intestinal problems and ageing.
- Research trends on the use of Green and Herbal teas for curing and preventing various diseases.
- Analysis of global Tea production volume and value by type and region during the 2013-2018 period, exports, imports, price trends and the competitive environment.
Additionally, profiles of 172 leading, public and private companies involved in the Tea industry as producers, distributors, retailers and consultants are given. The report, which also includes 61 tables and 20 figures, cost US$3900.
For further information contact:
Amadee+Company, Inc.
Tel: 1-305-450-1875
E-mail:
[email protected]
Source: Amadee+Company, Inc.
Published January 2014, a new report from Amadee+Company analyses and forecasts the tea industry for years 2013-2018. The report is titled, Tea: the Future Is Green And Herbal-Global Markets, Competitors And Opportunities: 2013-2018 Analysis And Forecasts.
According to Amadee+Company, the global market for tea is very large and estimated at USD15.4 billion in 2013, in terms of production value. While the Black/Other Teas segment is growing modestly (3.9% annually), production of Green Tea is growing rapidly (11% CAGR) and Herbal Teas are growing exponentially (>15% CAGR).
Further, Amadee+Company states that besides being a popular beverage, teas of various kinds can both prevent and cure diseases. This includes heart disease, cancer, diabetes, dementia, oral disease and ageing, among others. The company states that one reason is that tea is very rich in polyphenolic constituents, which have high anti-inflammatory, antioxidant, and antimutagenic properties. They use the example: a typical cup of brewed Green tea contains between 80 and 100 milligrams of polyphenols, with the catechin EGCG (a type of natural phenol) accounting for about 25 to 30 milligrams. Various studies have demonstrated that EGCG can inhibit carcinogenesis and prevent metastasis in established tumors.
Despite the exploding demand for tea, they state, little has been published on this market, especially the Green and Herbal segments. The Amadee+Company report looks in detail at the Tea market. Specifically, it provides: